Effects of a Seven-day BASIS™ Supplementation on Menopausal Syndromes and Measurements of the Urinary Vitamin B3 and Estradiol Levels in Pre-, Peri- and Post-menopause

Completed · Not applicable

Conditions studied: Menopause

In brief

The purpose of this study is to determine whether a short supplementation (7days) with BASIS™ increases the natural production of estradiol, measured in urinary waste. The overall objective is to determine whether through increased estradiol levels, the undesirable menopausal effects, assessed via questionnaires, are mitigated by a short-term supplementation with BASIS™

Key facts

Study ID

NCT04841499

Run by

University of South Alabama

People needed

40

Starts

2021-04-05

Expected to finish

2021-07-15

Last updated by the study team

2021-11-18

Who can join

Age: 35 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• 35 years of age or older
• pre, peri or post menopausal

You may not qualify if…

• Less than 35 years of age
• Hormone replacement therapy

Where it is running

• University of South Alabama — Mobile, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.